AstraZeneca (AZN)

Add to Watchlists Create an Alert
73.19 +0.08  +0.11% NYSE Jul 30, 5:00PM BATS Real time Currency in USD

AstraZeneca Cash from Financing (TTM):

-3.027B for March 31, 2014

View 4,000+ financial data types

View Full Chart

AstraZeneca Cash from Financing (TTM) Chart

Export Data
Save Image

AstraZeneca Historical Cash from Financing (TTM) Data

View and export this data going back to 1993. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
March 31, 2014 -3.027B
Dec. 31, 2013 -3.047B
Sept. 30, 2013 -3.773B
June 30, 2013 -1.697B
March 31, 2013 -3.717B
Dec. 31, 2012 -4.923B
Sept. 30, 2012 -6.079B
June 30, 2012 -8.318B
March 31, 2012 -8.952B
Dec. 31, 2011 -9.321B
Sept. 30, 2011 -9.46B
June 30, 2011 -8.81B
March 31, 2011 -7.803B
Dec. 31, 2010 -7.334B
Sept. 30, 2010 -5.45B
June 30, 2010 -6.273B
March 31, 2010 -4.713B
Dec. 31, 2009 -3.629B
Sept. 30, 2009 -5.193B
June 30, 2009 -5.904B
March 31, 2009 -6.235B
Dec. 31, 2008 -6.362B
Sept. 30, 2008 -5.065B
June 30, 2008 -5.01B
March 31, 2008 6.709B
   
Dec. 31, 2007 6.051B
Sept. 30, 2007 5.096B
June 30, 2007 4.725B
March 31, 2007 -6.763B
Dec. 31, 2006 -5.366B
Sept. 30, 2006 -4.965B
June 30, 2006 -4.762B
March 31, 2006 -4.656B
Dec. 31, 2005 -4.572B
Sept. 30, 2005 -4.456B
June 30, 2005 -4.892B
March 31, 2005 -3.739B
Dec. 31, 2004 -2.761B
Sept. 30, 2004 -3.523B
June 30, 2004 -3.302B
March 31, 2004 -3.125B
Dec. 31, 2003 -2.674B
Sept. 30, 2003 -2.892B
June 30, 2003 -2.132B
March 31, 2003 -3.308B
Dec. 31, 2002 -3.312B
Sept. 30, 2002 -2.094B
June 30, 2002 -2.555B
March 31, 2002 -1.942B
Dec. 31, 2001 -1.935B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Get data for
Advertisement

AZN Cash from Financing (TTM) Benchmarks

Companies
GlaxoSmithKline -12.34B
Pfizer -17.54B
AbbVie -3.137B

AZN Cash from Financing (TTM) Range, Past 5 Years

Minimum -9.46B Sep 2011
Maximum -1.697B Jun 2013
Average -5.869B

AZN Cash from Financing (TTM) Excel Add-In Codes

  • Metric Code: cash_financing_ttm
  • Latest data point: =YCP("AZN", "cash_financing_ttm")
  • Last 5 data points: =YCS("AZN", "cash_financing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.